Akram Echtay

790 total citations
30 papers, 610 citations indexed

About

Akram Echtay is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Akram Echtay has authored 30 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Akram Echtay's work include Diabetes Treatment and Management (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Diabetes Management and Research (7 papers). Akram Echtay is often cited by papers focused on Diabetes Treatment and Management (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Diabetes Management and Research (7 papers). Akram Echtay collaborates with scholars based in Lebanon, United Arab Emirates and United Kingdom. Akram Echtay's co-authors include Rita Nemr, Wassim Y. Almawi, Mohamed Hassanein, Abdullah Bennakhi, Naim Shehadeh, Valérie Pilorget, David R. Owens, Juliana C.N. Chan, Marie‐Paule Dain and Noha Irani‐Hakime and has published in prestigious journals such as The Lancet, Gene and Diabetes Obesity and Metabolism.

In The Last Decade

Akram Echtay

28 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akram Echtay Lebanon 12 346 266 147 116 86 30 610
Tony Bill Hansen Denmark 9 306 0.9× 91 0.3× 94 0.6× 108 0.9× 40 0.5× 9 411
Chih‐Tsueng He Taiwan 13 195 0.6× 105 0.4× 110 0.7× 34 0.3× 36 0.4× 28 440
Hannes Manell Sweden 10 222 0.6× 112 0.4× 76 0.5× 53 0.5× 177 2.1× 21 433
N Iqbal United States 10 216 0.6× 147 0.6× 104 0.7× 62 0.5× 143 1.7× 23 441
J. A. Torrens United Kingdom 3 283 0.8× 70 0.3× 62 0.4× 214 1.8× 41 0.5× 3 444
Daria Colligiani Italy 8 212 0.6× 184 0.7× 122 0.8× 14 0.1× 234 2.7× 9 429
A Aldibbiat United Kingdom 11 145 0.4× 54 0.2× 112 0.8× 65 0.6× 125 1.5× 14 388
F. Cambien France 7 271 0.8× 93 0.3× 64 0.4× 75 0.6× 139 1.6× 16 493
Kazuhiko Matsuzawa Japan 12 182 0.5× 63 0.2× 158 1.1× 29 0.3× 96 1.1× 30 452
Hugh M Mather United Kingdom 7 224 0.6× 87 0.3× 127 0.9× 24 0.2× 163 1.9× 9 390

Countries citing papers authored by Akram Echtay

Since Specialization
Citations

This map shows the geographic impact of Akram Echtay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akram Echtay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akram Echtay more than expected).

Fields of papers citing papers by Akram Echtay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akram Echtay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akram Echtay. The network helps show where Akram Echtay may publish in the future.

Co-authorship network of co-authors of Akram Echtay

This figure shows the co-authorship network connecting the top 25 collaborators of Akram Echtay. A scholar is included among the top collaborators of Akram Echtay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akram Echtay. Akram Echtay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Echtay, Akram, et al.. (2023). Diagnosis and Management of Obesity: A Joint Statement by Practicing Endocrinologists. Journal of Diabetes Mellitus. 13(2). 77–92.
2.
Hafidh, Khadija, et al.. (2022). Prevalence and risk factors of vascular complications in type 2 diabetes mellitus: Results from discover Middle East and Africa cohort. Frontiers in Endocrinology. 13. 940309–940309. 8 indexed citations
3.
Al‐Rubeaan, Khalid, Abdullah Bennakhi, Fahrı Bayram, et al.. (2022). Characteristics and Treatment Patterns of Patients with Type 2 Diabetes Mellitus in the Middle East and Africa Cohort of the DISCOVER Study Program: a Prospective Study. Diabetes Therapy. 13(7). 1339–1352. 3 indexed citations
4.
Abu‐Alfa, Ali K., et al.. (2022). Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications. Diabetes Therapy. 14(1). 11–28. 1 indexed citations
5.
Azar, Sami T., et al.. (2021). Characteristics and treatment patterns of patients with type 2 diabetes in Lebanon: the DISCOVER study. Eastern Mediterranean Health Journal. 27(5). 509–515. 3 indexed citations
6.
Azar, Sami T., et al.. (2021). Experts’ opinion on the detection and management of prediabetes in Lebanon. Science Progress. 104(3). 311999935–311999935. 1 indexed citations
7.
Echtay, Akram, Monira Al Arouj, Naim Shehadeh, et al.. (2020). Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM). Advances in Therapy. 37(4). 1550–1563. 24 indexed citations
8.
Hassanein, Mohamed, Akram Echtay, Cécile Dessapt-Baradez, et al.. (2019). The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study (DAR-MENA T2DM). Diabetes Research and Clinical Practice. 151. 275–284. 63 indexed citations
9.
10.
11.
Nemr, Rita, et al.. (2013). Lack of replication of common EXT2 gene variants with susceptibility to type 2 diabetes in Lebanese Arabs. Diabetes & Metabolism. 39(6). 532–536. 9 indexed citations
12.
Echtay, Akram, et al.. (2013). Clinical Experience with Insulin Detemir in Patients with Type 2 Diabetes from the Near East Countries. Diabetes Therapy. 4(2). 399–408. 7 indexed citations
13.
Almawi, Wassim Y., et al.. (2013). A replication study of 19 GWAS-validated type 2 diabetes at-risk variants in the Lebanese population. Diabetes Research and Clinical Practice. 102(2). 117–122. 36 indexed citations
14.
Echtay, Akram, et al.. (2013). Effectiveness and Safety of Aliskiren and Aliskiren Hydrochlorothiazide (HCT) in a Multiethnic, Real-World Setting. Advances in Therapy. 30(2). 176–189. 2 indexed citations
15.
Nemr, Rita, et al.. (2012). Strong association of common variants in the IGF2BP2 gene with type 2 diabetes in Lebanese Arabs. Diabetes Research and Clinical Practice. 96(2). 225–229. 29 indexed citations
16.
Mtiraoui, Nabil, Amira Turki, Rita Nemr, et al.. (2012). Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARγ, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs. Diabetes & Metabolism. 38(5). 444–449. 44 indexed citations
17.
Nemr, Rita, et al.. (2012). Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Lebanese subjects. Diabetes Research and Clinical Practice. 98(3). e23–e27. 19 indexed citations
18.
Aschner, Pablo, Juliana C.N. Chan, David R. Owens, et al.. (2012). Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial. The Lancet. 379(9833). 2262–2269. 82 indexed citations
19.
Nemr, Rita, et al.. (2011). Replication study of common variants in CDKAL1 and CDKN2A/2B genes associated with type 2 diabetes in Lebanese Arab population. Diabetes Research and Clinical Practice. 95(2). e37–e40. 30 indexed citations
20.
Echtay, Akram, Ilana Harman‐Boehm, Abdulmohsen Al Elq, et al.. (2011). The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial. International Journal of Clinical Practice. 65(11). 1132–1140. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tony Bill Hansen Breakdown of academic impact, for papers by Chih‐Tsueng He Breakdown of academic impact, for papers by Hannes Manell Breakdown of academic impact, for papers by N Iqbal Breakdown of academic impact, for papers by J. A. Torrens Breakdown of academic impact, for papers by Daria Colligiani Breakdown of academic impact, for papers by A Aldibbiat Breakdown of academic impact, for papers by F. Cambien Breakdown of academic impact, for papers by Kazuhiko Matsuzawa Breakdown of academic impact, for papers by Hugh M Mather
Rankless by CCL
2026